Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 36 citing articles:

Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppression
Anna Rea, Sara Santana-Hernández, Javier Rodríguez Villanueva, et al.
Nature Immunology (2025)
Open Access | Times Cited: 2
Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy
Marisa K. Kilgour, Donald Bastin, Seung‐Hwan Lee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 42
Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells
Jaya Lakshmi Thangaraj, Michael Coffey, Edith Lopez, et al.
Cell stem cell (2024) Vol. 31, Iss. 9, pp. 1327-1343.e5
Closed Access | Times Cited: 16
Reprogramming natural killer cells for cancer therapy
Kexin Wang, Linqin Wang, Yiyun Wang, et al.
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 2835-2855
Closed Access | Times Cited: 10
Protocol for isolation and expansion of natural killer cells from human peripheral blood scalable for clinical applications
Soumyadipta Kundu, Leonie Durkan, Michael O’Dwyer, et al.
Biology Methods and Protocols (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Progress in the treatment of advanced hepatocellular carcinoma with immune combination therapy
Di Pan, Haonan Liu, Pengfei Qu, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 2, pp. 273-286
Open Access | Times Cited: 7
The application of autologous cancer immunotherapies in the age of memory-NK cells
Gaby D. Lizana‐Vasquez, Madeline Torres‐Lugo, R. Brent Dixon, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Key oncogenic signaling pathways affecting tumor-infiltrating lymphocytes infiltration in hepatocellular carcinoma: basic principles and recent advances
Xiang Wang, Zijun Yuan, Zhengbo Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers
Junaid Arshad, A. Ramachandra Rao, Matthew Leonard Repp, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2985-2985
Open Access | Times Cited: 5
Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy
Hai Feng, Yunhui Zhuo, Xuemei Zhang, et al.
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 1109-1125
Open Access | Times Cited: 20
The Important Roles of Natural Killer Cells in Liver Fibrosis
Ming Yang, Ethan Vanderwert, Eric T. Kimchi, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1391-1391
Open Access | Times Cited: 10
Current Landscape of Adoptive Cell Therapy and Challenge to Develop “Off‐The‐Shelf” Therapy for Hepatocellular Carcinoma
Seung Kak Shin, Y. Mishima, Yoonseok Lee, et al.
Journal of Gastroenterology and Hepatology (2025)
Open Access
Exploring the efficacy of fluorouracil and platinum based chemotherapy in advanced hepatocellular carcinoma to bridge the treatment gap in resource limited settings
Se Jun Park, Kabsoo Shin, In‐Ho Kim, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Emerging insights into the gut microbiota as a key regulator of immunity and response to immunotherapy in hepatocellular carcinoma
Siqi Ren, Yinping Zhang, Xingyue Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Novel Agents and Drug Development
Issac R. Schwantes, Paul Wong, Ajay V. Maker, et al.
(2025), pp. 311-321
Closed Access
The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances
Paula Morcillo-Martín-Romo, Javier Valverde-Pozo, María Ortiz-Bueno, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 857-857
Open Access
Exploration of the role of immune cells and cell therapy in hepatocellular carcinoma
Tao Zhang, Chongyang Ren, Zhanyu Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Prunella vulgaris: A potential molecule for the treatment of hepatocellular carcinoma
Jie Lin, Jiaqiang Zhou, K. L. Ye, et al.
Medicine (2025) Vol. 104, Iss. 17, pp. e42267-e42267
Open Access
The progress of natural killer cells in the treatment of immune response to hepatocellular carcinoma

New medicine. (2025), pp. 1-7
Closed Access
Cytokines in Focus: IL-2 and IL-15 in NK Adoptive Cell Cancer Immunotherapy
Bryan Marr, Donghyeon Jo, Mihue Jang, et al.
Immune Network (2025) Vol. 25, Iss. 2
Open Access
Natural Born Killers: Harnessing NK Cells to Treat Cancer
Kanchi Patell, Katherine W. Myers, Amr Mohamed, et al.
Best Practice & Research Clinical Haematology (2025), pp. 101630-101630
Closed Access
Natural killer cell-based cancer immunotherapy: from basics to clinical trials
Ying‐Hong Shi, Donglin Hao, Hui Qian, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Efficacy and safety of natural killer cell therapy in patients with solid tumors: a systematic review and meta-analysis
Hee-Sook Park, Gahee Kim, Na Jin Kim, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Advances in Targeted Immunotherapy for Hepatobiliary Cancers
Samantha M. Ruff, Alexander H. Shannon, Timothy M. Pawlik
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13961-13961
Open Access | Times Cited: 12
Adaptive natural killer cell expression in response to cytomegalovirus infection in blood and solid cancer
Suruthimitra Okpoluaefe, Ida Shazrina Ismail, Rafeezul Mohamed, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e32622-e32622
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top